Showing results (321-330 of 595) with videos related to

Sort By:
Pageof 60
Clinical Rheumatology|September 30, 2020
Evaluation of the thyroid disorders in children with familial Mediterranean feverHande Turan, Mehmet Yildiz, Orkun Civan, et al.
Expert Opinion on Drug Safety|July 29, 2024
Long-term safety profile and secondary effectiveness of canakinumab in pediatric rheumatic diseases: a single-center experienceElif Kilic Konte, Nergis Akay, Umit Gul, et al.
Rheumatology International|September 18, 2022
Long-term efficacy of tonsillectomy/adenotonsillectomy in patients with periodic fever aphthous stomatitis pharyngitis adenitis syndrome with special emphasis on co-existence of familial Mediterranean feverE Deniz Gozen, Mehmet Yildiz, Sinem Kara, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 19, 2021
Variability in reporting of key outcome predictors in acute myocardial infarction cardiogenic shock trialsJeffrey M Tyler, Christopher Brown, Jacob Colin Jentzer, et al.
The American Journal of Cardiology|April 26, 2006
Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarctionMarc C Newell, Christopher R Henry, Christopher J G Sigakis, et al.
American Heart Journal|February 16, 2023
Microvascular obstruction identifies a subgroup of patients who benefit from stem cell therapy following ST-elevation myocardial infarctionSarah J Davidson, Jerome Roncalli, Daniel Surder, et al.
American Heart Journal|September 29, 2014
The impact of prolonged lower limb ischemia on amputation, mortality, and functional status: the FRIENDS registrySue Duval, Hong H Keo, Niki C Oldenburg, et al.
Critical Pathways in Cardiology|July 26, 2014
Ranolazine refractory angina registry: 1-year resultsNoel M Bennett, Vijay Iyer, Theresa L Arndt, et al.
Circulation|September 21, 2011
Causes of delay and associated mortality in patients transferred with ST-segment-elevation myocardial infarctionMichael D Miedema, Marc C Newell, Sue Duval, et al.
American Heart Journal|September 10, 2010
Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarctionJay H Traverse, David H McKenna, Karen Harvey, et al.
Pageof 60